Article info

Download PDFPDF
Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy

Authors

  1. Correspondence to Dr Shang Hung Chen, Division of Hematology and Oncology, Department of Internal Medicine, Chi-Mei Medical Center, No.201, Taikang, Taikang Vil., Liuying Dist., Tainan City 736, Taiwan; bryanchen0615{at}gmail.com
View Full Text

Citation

Li C, He H, Wang J, et al
Fibroblast growth factor receptor 2 overexpression is predictive of poor prognosis in rectal cancer patients receiving neoadjuvant chemoradiotherapy

Publication history

  • Received July 9, 2014
  • Revised September 5, 2014
  • Accepted September 11, 2014
  • First published September 30, 2014.
Online issue publication 
November 14, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.